Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Alpha-synuclein
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Autoproteolytic activity == The use of high-resolution [[Ion-mobility spectrometry–mass spectrometry|ion-mobility mass spectrometry]] (IMS-MS) on HPLC-purified alpha-synuclein ''in vitro'' has shown alpha-synuclein to be [[autoproteolytic]] (self-[[Proteolysis|proteolytic]]), generating a variety of small [[molecular weight]] fragments upon incubation.<ref name="Vlad_2011">{{cite journal | vauthors = Vlad C, Lindner K, Karreman C, Schildknecht S, Leist M, Tomczyk N, Rontree J, Langridge J, Danzer K, Ciossek T, Petre A, Gross ML, Hengerer B, Przybylski M | title = Autoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometry | journal = ChemBioChem | volume = 12 | issue = 18 | pages = 2740–2744 | date = December 2011 | pmid = 22162214 | pmc = 3461308 | doi = 10.1002/cbic.201100569 }}</ref> The 14.46 [[Kilodalton|kDa]] protein was found to generate numerous smaller fragments, including 12.16 kDa ([[amino acids]] 14–133) and 10.44 kDa (40–140) fragments formed through [[C-terminus|C-]] and [[N-terminus|N-terminal]] truncation and a 7.27 kDa C-terminal fragment (72–140). The 7.27 kDa fragment, which contains the majority of the NAC region, aggregated considerably faster than full-length alpha-synuclein. It is possible that these autoproteolytic products play a role as intermediates or cofactors in the aggregation of alpha-synuclein ''in vivo''.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)